COVID-19 INFECTION IN THE CHILD, IN A SUPPORT HOSPITAL, DURING THE ALERT STATE
Received
14 January 2021
Revised
27 February 2021
Accepted
12 March 2021
Available Online
15 March 2021
Abstract
THE UNPRECEDENTED PERIOD WE AR E GOING THROUGH FORCES US, ALL CLINICIANS, TO OBSERVE THE MANIFESTATIONS OF COVID-19 INFECTION, AT VARIOUS AGES. IN CHILDREN, AS A PECULIARITY, IN 12 MONTHS OF PANDEMIC, THE PREVALENCE OF POSITIVE CASES IN THE TOTAL NUMBER OF H OSPITALIZATIONS WAS LOW, BELO W 10%. T HE SEVERITY OF THE REPORTED CASES WAS LOWER THAN IN ADULTS, AND THE DIGESTIVE MANIFESTATIONS WERE IN THE FOREGROUND, TO THE DETRIMENT OF THE RESPIRATORY ONES, THESE BEING THE 2 LARGE GROUPS OF DISEASES STUDIED COMPARATIVELY CHILD-ADULT. NEUROLOGICAL MANIFESTATIONS WERE ABSENT IN DIAGNOSED AND HOSPITALIZED CASES.
Keywords
CHILD
COVID-19 INFECTION.
Full Text
The body of this article is intentionally hidden on the public page. Please use the PDF reader or the PDF download for the complete text.
References
[1]
Yan CH, Faraji F, Prajapati DP, Boone CE, DeConde AS. Association of chemosensory dysfunction an d COVID-19 in patients presenting with influenza -like symptoms. Int Forum Allergy Rhinol. 2020 Jul;10(7):806-813.
[2]
Posfay-Barbe KM, Wagner N, Gauthey M, et al. COVID-19 in children and the dynamics of infection in families. Pediatrics. 2020;146(2):e20201576
[3]
Park YJ, Choe YJ, Park O, et al. Contact tracing during coronavirus disease outbreak, South Korea, 2020. Emerg Infect Dis. 2020;26(10):2465–2468
[4]
Heald-Sargent T, Muller WJ, Zheng X, Rippe J, Patel AB, Kociolek LK . Age-related differences in nasopharyngeal severe acute respiratory syndrome coronavirus 2 (SARS -CoV-2) levels in patients with mild to moderate coronavirus disease 2019 (COVID-19). JAMA Pediatr. 2020;174(9):902–903
[5]
Yonker LM, Neilan AM, Bartsch Y, et al. Pediatric Severe Acute Respiratory Syndrome Coronavirus 2 (SARS -CoV-2): clinical presentation, infectivity, and immune responses. J Pediatr. 2020;S002 2- 3476(20):31023–31024
[6]
Huang CL, Wang YM, Li XW, Ren LL, Zhao JP, Hu Y, et al . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506.
[7]
Armann JP , Diffloth N , Simon A , et al. Hospital admission in children and adolescents with COVID-19. Dtsch Arztebl Int. 2020;117(21):373-374.
[8]
Rajapakse N, Dixit D . Human and novel coronavirus infections in children: a review. Paediatr Int Child Health. 2020;1-20.
[9]
Pollán M , Pérez-Gómez B, Pastor-Barriuso R , et al ; ENE-COVID Study Group. Prevalence of SARS-CoV-2 in Spain (ENE -COVID): a nationwide, population -based seroepidemiological study. Lancet. 2020;396(10250):535-544.
[10]
Gudbjartsson DF , Helgason A , Jonsson H , et al. Spread of SARS -CoV-2 in the Icelandic population. N Engl J Med. 2020;382(24):2302-2315.